Product Information
SACUBITRIL-VALSARTAN 24-26 MG is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.4985 per EA under NDC 69238273101. Its NADAC has been published 56 times since Sep 10, 2025.
FDA first approved this application on May 28, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
24; 26 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238273101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SACUBITRIL; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA213605FDA Approved
5/28/2024
TE Code
AB
On Market Since
6/2/2025
Pharmacological Classes
Price Statistics
The NADAC for SACUBITRIL-VALSARTAN 24-26 MG has been published 56 times since Sep 10, 2025, and over the history we have for it it has declined 59.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4985 per EA |
|---|---|
| All-time high | $1.2332 (Oct 15, 2025) |
| All-time low | $0.4972 (Jul 22, 2026) |
| 52-week high | $1.2332 |
| 52-week low | $0.4972 |
| Median price | $0.6259 |
| Average price | $0.7389 |
| Largest weekly change | -18.1% (Oct 22, 2025) |
| Weeks tracked | 56 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sacubitril and Valsartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SACUBITRIL-VALSARTAN 24-26 MG?
The current National Average Drug Acquisition Cost (NADAC) for SACUBITRIL-VALSARTAN 24-26 MG, manufactured by Amneal Pharmaceuticals NY LLC, is $0.4985 per EA (NDC 69238273101), effective Sep 30, 2026.
How has the price of SACUBITRIL-VALSARTAN 24-26 MG changed over time?
Over the history we have for it, the NADAC for SACUBITRIL-VALSARTAN 24-26 MG has declined 59.6%. It has been tracked across 56 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for SACUBITRIL-VALSARTAN 24-26 MG?
Since Sep 10, 2025, the NADAC for SACUBITRIL-VALSARTAN 24-26 MG has ranged from a low of $0.4972 (Jul 22, 2026) to a high of $1.2332 (Oct 15, 2025), with a median of $0.6259 per EA.
Are there cheaper alternatives to SACUBITRIL-VALSARTAN 24-26 MG?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SACUBITRIL-VALSARTAN 24-26 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures SACUBITRIL-VALSARTAN 24-26 MG?
SACUBITRIL-VALSARTAN 24-26 MG (NDC 69238273101) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.